Acrylamide derivatives as Fab I inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8895545
SERIAL NO

13644351

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In part, the present invention is directed to antibacterial compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • DEBIOPHARM INTERNATIONAL SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pauls, Heinz W Oakville, CA 57 607
Ramnauth, Jailall Brampton, CA 23 269
Sampson, Peter Oakville, CA 6 66
Toro, Andras Oxnard, US 12 45

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 25, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00